JP Morgan Put 135 PSX 16.08.2024/ DE000JB996G5 /
6/25/2024 10:51:48 AM | Chg.- | Bid11:30:12 AM | Ask11:30:12 AM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.630EUR | - | 0.530 Bid Size: 3,000 |
0.580 Ask Size: 3,000 |
Phillips 66 | 135.00 USD | 8/16/2024 | Put |
GlobeNewswire
6/26
EyePoint Pharmaceuticals to Highlight DURAVYUTM (vorolanib intravitreal insert) Clinical and Regulat...
GlobeNewswire
6/25
FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technolog...
GlobeNewswire
6/20
The International Food Information Council (IFIC) Releases Annual Food & Health Survey Revealing Ris...
GlobeNewswire
6/17
Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2024 Earnings Conference Call
GlobeNewswire
6/17
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire
6/12
Greystone Closes $22.9 Million in Total Debt Placement and Preferred Equity Financing for Fort Worth...
GlobeNewswire
6/5
EyePoint Pharmaceuticals to Present at Goldman Sachs 45th Annual Global Healthcare Conference
GlobeNewswire
5/22
Entero Therapeutics to Present Corporate Update at 2024 BIO International Convention
GlobeNewswire
5/20
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease We...
GlobeNewswire
5/16
Optimal Daily Dairy Consumption Remains Elusive Despite Well-Established Health Benefits
GlobeNewswire
5/16
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Newsfile Corp
5/15
King Fuels Announces Strategic Expansion of Its Fuel Distribution Network in Texas, Colorado, Kansas...